DRTS
Alpha Tau Medical Ltd.
NASDAQ · Healthcare · Biotechnology · IL
$13.23
−0.90%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 166.57x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 27.73x
- Price / sales
- —
- Price / cash flow
- -45.78x
Enterprise value
- Enterprise value
- $1.1B
- EV / sales
- —
- EV / EBITDA
- -23.15x
- EV / EBIT
- -22.53x
- Market cap
- $1.2B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026